Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PSTI

Pluristem Therapeutics (PSTI)

Pluristem Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PSTI
DateTimeSourceHeadlineSymbolCompany
09/06/202320:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PSTIPluristem Therapeutics Inc
02/06/202306:06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PSTIPluristem Therapeutics Inc
10/05/202306:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSTIPluristem Therapeutics Inc
26/04/202306:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
27/02/202323:58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PSTIPluristem Therapeutics Inc
27/02/202323:53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PSTIPluristem Therapeutics Inc
17/02/202300:59Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PSTIPluristem Therapeutics Inc
17/02/202300:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PSTIPluristem Therapeutics Inc
14/02/202322:27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PSTIPluristem Therapeutics Inc
14/02/202308:39Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PSTIPluristem Therapeutics Inc
07/02/202301:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
25/01/202308:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
29/12/202208:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
23/12/202200:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PSTIPluristem Therapeutics Inc
20/12/202208:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
11/11/202208:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PSTIPluristem Therapeutics Inc
14/10/202207:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
30/09/202200:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
22/09/202207:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PSTIPluristem Therapeutics Inc
22/09/202206:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PSTIPluristem Therapeutics Inc
25/07/202223:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
25/07/202221:00GlobeNewswire Inc.Pluri CEO Issues Shareholder UpdateNASDAQ:PSTIPluristem Therapeutics Inc
25/07/202215:00GlobeNewswire Inc.Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.” Reflecting the Company’s Strategy to Leverage its Innovative 3D Cell-based Technology Platform to Additional IndustriesNASDAQ:PSTIPluristem Therapeutics Inc
17/07/202222:20TipRanksPluristem (PSTI) Receives a Buy from H.C. WainwrightNASDAQ:PSTIPluristem Therapeutics Inc
13/07/202223:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
13/07/202220:00GlobeNewswire Inc.Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture SurgeryNASDAQ:PSTIPluristem Therapeutics Inc
24/06/202206:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PSTIPluristem Therapeutics Inc
15/05/202222:25TipRanksDawson James Thinks Pluristem’s Stock is Going to RecoverNASDAQ:PSTIPluristem Therapeutics Inc
28/03/202218:00GlobeNewswire Inc.Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New PartnershipNASDAQ:PSTIPluristem Therapeutics Inc
23/03/202222:30GlobeNewswire Inc.Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood TransfusionsNASDAQ:PSTIPluristem Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PSTI